The Abiraterone Dosing Chess Match With Johnson & Johnson-Back in Check
Russell Z Szmulewitz1, Walter M Stadler1, Mark J Ratain1
1Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
JAMA Oncology
|March 4, 2021
Abstract
No abstract available in PubMed .


